Skip to main content

Table 1 Effect of silymarin on liver weight, liver weight/body weight ratio, body mass index, body weight gain

From: Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats

Group

Weight measurement

Liver weight(g)

Liver weight/body weight (g/g)

Body mass index (kg/m2)

Body Weight Gain(g)

NC

6.24 ± 0.53

0.025 ± 0.002

5.66 ± 0.18

71.67 ± 27.05

FC

6.98 ± 0.24*

0.029 ± 0.003

5.70 ± 0.39

79.67 ± 19.36

SC

6.34 ± 0.41

0.026 ± 0.002

5.65 ± 0.19

71.83 ± 9.15

FTH

6.71 ± 0.33

0.027 ± 0.003

5.81 ± 0.48

74.33 ± 17.67

FFH

6.50 ± 0.36

0.026 ± 0.004

5.75 ± 0.28

72.67 ± 25.90

  1. At the end of the trial liver weight, liver weight/body weight ratio, body mass index and body weight gain were measured and calculated. NC normal control, FC fructose control, SC silymarin control, FTH fructose + 200 mg/kg silymarin, FFH fructose + 400 mg/kg silymarin. Data were presented as mean ± SD. N = 6 for each group. * p < 0.05 vs. NC
Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us